CCDC73 Activators
Chemical activators of CCDC73 employ various cellular mechanisms to modulate its activity. Forskolin, a potent activator of adenylate cyclase, increases intracellular cAMP levels, which in turn activate protein kinase A (PKA). PKA is known to phosphorylate a myriad of proteins, and if CCDC73 is among its substrates, this could lead to its activation. Similarly, dibutyryl-cAMP, a cAMP analog, can permeate cell membranes and activate PKA, suggesting another route through which CCDC73 may be activated if it is responsive to PKA signaling. PMA, or phorbol 12-myristate 13-acetate, functions through activation of protein kinase C (PKC), which phosphorylates various proteins. If CCDC73 is a PKC substrate or is part of the PKC signaling pathway, PMA can trigger its activation. Moreover, ionomycin, by raising intracellular calcium levels, can activate calmodulin-dependent kinases, which could phosphorylate CCDC73, leading to its activation.
Insulin, through its activation of the PI3K/Akt signaling pathway, can lead to the phosphorylation and activation of various proteins including CCDC73, if it is influenced by this pathway. Epidermal Growth Factor (EGF), which activates the EGFR tyrosine kinase, can initiate signaling cascades such as the MAPK/ERK pathway, potentially leading to CCDC73 phosphorylation if it is part of this network. Anisomycin, a stress-activated protein kinase activator, could similarly facilitate CCDC73 activation via JNK signaling. In contrast, compounds like Calyculin A and Okadaic Acid, which inhibit protein phosphatases, might lead to the activation of CCDC73 by preventing its dephosphorylation, hence sustaining an active phosphorylation state. Zaprinast, by inhibiting phosphodiesterase type 5, elevates cAMP and cGMP, which activate PKA or PKG. If CCDC73 activation is contingent on these kinases, Zaprinast can be a pertinent activator. Lastly, the use of chelerythrine, a PKC inhibitor, can help delineate the role of PKC in CCDC73 activation by showing the effects of PKC inhibition on CCDC73's activity state.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can phosphorylate and thus activate a multitude of downstream proteins, potentially including CCDC73 if it is a substrate for PKC or if PKC-mediated signaling creates an environment that promotes CCDC73 activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, which can activate calmodulin-dependent kinase (CaMK). Activated CaMK can then phosphorylate various target proteins, potentially including CCDC73, thus leading to its functional activation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt signaling pathway, which can lead to the phosphorylation and activation of downstream proteins. If CCDC73 is a target or part of the cascade that is influenced by Akt, then insulin could lead to its functional activation through this signaling pathway. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is known to activate stress-activated protein kinases such as JNK. Activation of JNK can lead to the phosphorylation of various proteins, possibly including CCDC73, if it is a substrate for JNK or involved in JNK signaling pathways, thereby enabling its functional activation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 and 2A. By inhibiting these phosphatases, it prevents the dephosphorylation of proteins, potentially leading to the sustained activation of proteins like CCDC73 if they are regulated by phosphorylation states maintained by these phosphatases. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA. Activation of PKA can phosphorylate a broad range of substrates within the cell, potentially including CCDC73, leading to its activation if CCDC73 is a PKA substrate or is regulated by PKA-dependent signaling pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Similar to Calyculin A, Okadaic Acid is a potent inhibitor of protein phosphatases, particularly PP2A. By preventing dephosphorylation, it could lead to the activation of proteins that are typically regulated by phosphorylation, like CCDC73, assuming CCDC73 activity is controlled by phosphorylation status. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterase type 5 (PDE5), leading to an increase in cAMP and cGMP levels. This elevation can activate PKA or PKG, which, if CCDC73 is a substrate or involved in the signaling cascades influenced by these kinases, can lead to CCDC73 activation. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is a selective inhibitor of PKC. While it typically inhibits PKC, it can be used experimentally to understand the role of PKC in signaling pathways. If CCDC73 activation is downstream of PKC, then manipulating PKC activity with chelerythrine could elucidate its role in CCDC73 activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K. By inhibiting PI3K, it can indirectly lead to the activation of alternate compensatory pathways that may result in the activation of CCDC73, assuming CCDC73 is regulated by such compensatory mechanisms in the context of PI3K pathway inhibition. | ||||||